Kiaie Namvar 4/A
4/A · ADiTx Therapeutics, Inc. · Filed Oct 16, 2020
Insider Transaction Report
Form 4/AAmended
Kiaie Namvar
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-10-13+10,000→ 10,000 totalExercise: $1.94Exp: 2030-10-13→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020.